Biotech

All Articles

Novo inks $600M NanoVation deal to study genetic medicines ex-liver

.Novo Nordisk is continuing its press in to hereditary medications, consenting to compensate NanoVat...

Innovent web links cytokine to colorectal cancer feedbacks

.Innovent Biologics has made the instance that its own checkpoint inhibitor-cytokine fusion protein ...

Merck, Daiichi ADC hits goal in period 3 bronchi cancer cells research study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens AI center with collab to pick cancer aim ats

.5 months after Rakovina Therapeutics pivoted towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medication smash hits in stage 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, disclosing period...

Despite ph. 3 overlook, Alkeus sees course in advance for eye condition asset

.Though Alkeus Pharmaceuticals' oral eye condition property failed to substantially decrease geograp...

Kairos goes social along with $6M IPO to fund tests of cancer cells medication

.With a trio of biotechs striking the Nasdaq on Friday, it was actually effortless to miss a smaller...

Vaccine and Keytruda combo helpful in squamous cell carcinoma

.Immune system gate preventions are the superheroes of cancer treatment. Medicines like Bristol Myer...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings as ...

Regeneron's Opdualag rival shows 57% action price

.Regeneron is actually back with long-lasting consequence for its own LAG-3 prevention as well as PD...